Dr Federico Paoletti tells us why he founded https://exogene.co.uk/ (Exogene) and his hopes for innovating T-cell receptor-based cancer immunotherapies using AI. He also discusses the challenges he faces today, having raised a seed round earlier this year. Federico also recommends a book every founder should read as well as a series that sheds unusual insight into the life of a start-up. Exogene is based in Oxford UK and supported by the https://www.bioescalator.ox.ac.uk/ (Oxford BioEscalator).